MedTrace Logo

Patient Profiling and Provider Feedback to Reduce Adverse Drug Events

NCT00013143 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2015-04-07

No results posted yet for this study

Summary

Adverse drug events (ADE) present a unique focus for error reduction. Computerized provider order entry, with embedded clinical decision support, has great promise in reducing medication errors but preventable adverse drug events may still occur despite such systems.

Conditions

  • Adverse Drug Events

Interventions

BEHAVIORAL

Patient risk profiling (potential ADEs) w/provider feedback

Sponsors & Collaborators

Principal Investigators

  • Peter A. Glassman, MBBS MSc · VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Completion
2003-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00013143 on ClinicalTrials.gov